Ganciclovir treatment of hepatitis B virus infection in liver transplant recipients

Hepatology

Volumn 23, Issue 1, 1996, Pages 1-7

  Gish, Robert G ^a   Lau, Johnson Y N ^a   Brooks, Linda ^a   Fang, Jane W S ^a   Steady, Stephen L ^a   Imperial, Joanne C ^a   Garcia Kennedy, Richard ^b   Esquivel, Carlos O ^a   Keeffe, Emmet B ^a  

^a CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GANCICLOVIR;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIGEN EXPRESSION; ARTICLE; CHILD; CLINICAL ARTICLE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HISTOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; LIVER TRANSPLANTATION; MALE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SURVIVAL; VIRUS INFECTION;

EID: 0030061482     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.1996.v23.pm0008550028     Document Type: Article

References (21)

1. Samuel D, Muller R, Alexander G, Fassati L, Ducot B, Benhamou JP, Bismuth H. Liver transplantation in European patients with the hepatitis B surface antigen. N Engl J Med 1993;329:1842-1847.
2. Samuel D, Bismuth A, Mathieu D, Arulnaden J, Reynes M, Benhamou J, Brechot G, et al. Passive immunoprophylaxis after liver transplantation in HBsAg-positive patients. Lancet 1991;337:813-815.
3. Todo S, Demetris AJ, Van Thiel D, Tepperman L, Fung JJ, Starzl TE. Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease. HEPATOLOGY 1991;13:619-626.
4. O'Grady JG, Smith HM, Davis SE, Daniels HM, Donaldson PT, Tan KG, Portmann B, et al. Hepatitis B virus reinfection after orthotopic liver transplantation: serological and clinical implications. J Hepatol 1992;14:104-111.
5. Perrillo RP, Schiff ER, Davis GL, Bodenheimer HC, Lindsay K, Payne J, Dienstag JL, et al. A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. N Engl J Med 1990;323:295-301.
6. Wright HI, Gavaler JS, Van Thiel DH. Preliminary experience with alpha 2b interferon therapy of viral hepatitis in liver allograft recipients. Transplantation 1992;53:121-124.
7. Marcellin P, Samuel D, Loriot MA, Areias J, Bismuth H, Benhamou JP. Anti-viral effect of adenine arabinoside monophosphate (ARA-AMP) in patients with recurrence of hepatitis B virus (HBV) infection after liver transplantation [Abstract]. HEPATOLOGY 1990;12:966A.
8. Crippin J, Foster B, Carlen S, Borcich A, Bodenheimer H Jr. Retransplantation in hepatitis B - a multicenter experience. Transplantation 1994;57:823-826.
9. Chossegros P, Pouteil-Noble C, Samuel D, Causse X, Ouzan D, Bizollon T, Touraine JL, et al. Ganciclovir is an effective antiviral agent for post-transplantation chronic HBV infections, maintenance therapy may be required in some cases [abstract]. Gastroenterology 1993;104:A888.
10. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. HEPATOLOGY 1981;1:431-435.
11. Naoumov NV, Portmann BS, Tedder RS, Ferns B, Eddleston ALWF, Alexander GJM, Williams R, et al. Detection of hepatitis B virus antigens in liver tissue: a relation to viral replication and histology in chronic hepatitis B infection. Gastroenterology 1990;99:1248-1253.
12. Mondelli MU, Tedder RS, Ferns B, Pontisso P, Realdi G, Alberti A. Differential distribution of hepatitis core and e antigens in hepatocytes: analysis by monoclonal antibodies. HEPATOLOGY 1986;6:199-204.
13. Wu PC, Lau JYN, Lau S, Lau T, Lai CL. Relationship between intrahepatic expression of hepatitis B viral antigens and histology in Chinese patients with chronic hepatitis B virus infection. Clin Microbiol Infect Dis 1993;100:648-653.
14. Lau JYN, Naoumov NV, Alexander GJM, Williams R. Rapid detection of HBV DNA in liver tissue by in-situ hybridisation and its combination with immunohistochemistry for simultaneous detection of hepatitis B viral (HBV) antigens. J Clin Pathol 1991;44:905-908.
15. Berninger M, Hammer M, Hoyer B, Gerin JL. An assay for the detection of the DNA genome of hepatitis B virus in serum. J Med Virol 1982;9:57-68.
16. Ono Y, Onda H, Sasada R, Igarashi K, Sugino Y, Nishioka K The complete nucleotide sequences of the cloned hepatitis B virus DNA; subtype adr and adw. Nucleic Acids Res 1983;11:1747-1757.
17. Davies SE, Portmann BC, O'Grady JG, Aldis PM, Chaggar K, Alexander GJ, Williams R. Hepatic histological findings after transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitis. HEPATOLOGY 1991;13:150-157.
18. Benner KG, Lee RG, Keeffe EB, Lopez RR, Sasaki AW, Pinson CW. Fibrosing cytolytic liver failure secondary to recurrent hepatitis B after liver transplantation. Gastroenterology 1992;103:1307-1312.
19. Lau JYN, Davies SE, Bain VG, O'Grady JG, Alberti A, Alexander GJM, Williams R. High level expression of hepatitis B viral antigens in fibrosing cholestatic hepatitis. Gastroenterology 1992;102:956-962.
20. Fang JWS, Wright TL, Lau JYN. Fibrosing cholestatic hepatitis in a patient with HIV and hepatitis B (letter). Lancet 1993;342:1175.
21. Chen CH, Chen PJ, Chu JS, Yeh KH, Lai MY, Chen DS. Fibrosing cholestatic hepatitis in a hepatitis B surface antigen carrier after renal transplantation. Gastroenterology 1994;107:1514-1518.